zinc acetate

ApprovedSmall molecule

NNobelpharma

zinc acetate is one of 153 small molecule programs targeting Ischemic Cardiomyopathy. It is currently in Approved.

Indications

Total Trials

Active Trials

152

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ischemic CardiomyopathyActive, not recruiting

Wilson DiseaseActive, not recruiting

PneumoniaActive, not recruiting

Cystic FibrosisActive, not recruiting

Chronic CoughActive, not recruiting

Oral MucositisActive, not recruiting

Ischemic CardiomyopathyPhase 1

Active, not recruiting

Wilson DiseaseApproved

Active, not recruiting

PneumoniaPhase 3

Active, not recruiting

Cystic FibrosisPreclinical

Active, not recruiting

Chronic CoughPhase 2

Active, not recruiting

Oral MucositisPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

zinc acetate

NNobelpharma

Approved

1 2

Primaxin

Pfizer

Preclinical

2 3

Jakafi

Incyte

Preclinical

1 4

Primaquine

Sanofi

Preclinical

1 5

Acanya

Pfizer

Preclinical

1 6

Prevacid

Takeda

Preclinical

1 7

Innohep

Alnylam Pharmaceuticals

Preclinical

1 8

Avlosulfon

AAlmirall, S.A.

Preclinical

4 9

Neutrexin

WWest Japan Thoracic Oncology Group

Preclinical

12 10

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Efficacy and Safety1 trial

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Completed·NNobelpharma·Phase 3·NCT00212368

Pneumonia1 trial

The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children

Completed·MMakerere University·Phase 3·NCT00373100·328 enrolled

Ischemic Cardiomyopathy1 trial

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Completed·UUniversity of Michigan·Phase 1·NCT00696410·48 enrolled

Chronic Cough1 trial

Pilot of Zinc Acetate to Improve Chronic Cough

Completed·JJohns Hopkins University·Phase 2·NCT03135522·34 enrolled

Cystic Fibrosis1 trial

Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)

Completed·CCystic Fibrosis Foundation·N/A·NCT00104494·30 enrolled

2 more indications

Wilson disease1 trial

Study of Zinc for Wilson Disease

Completed·NNational Center for Research Resources (NCRR)·Phase 4·NCT00004338·300 enrolled

Oral Mucositis1 trial

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Completed·PPanineeya Mahavidyalaya Institute of Dental Sciences & Research Centre·Phase 2/3·NCT02868151·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for zinc acetate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — zinc acetate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for zinc acetate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Nobelpharma company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNobelpharma

zinc acetate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Efficacy and Safety1 trial

Pneumonia1 trial

Ischemic Cardiomyopathy1 trial

Chronic Cough1 trial

Cystic Fibrosis1 trial

Wilson disease1 trial

Oral Mucositis1 trial

References

Drug Info

Quick Facts

Related News